Unlock instant, AI-driven research and patent intelligence for your innovation.

Novel pharmaceutical dosage forms and method for producing same

A pharmaceutical dosage form and dosage form technology, applied in the field of new dosage forms

Inactive Publication Date: 2005-07-13
SMITHKLINE BECKMAN CORP
View PDF9 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Apparently, the setbacks experienced by drug manufacturers in their attempts to produce tablets by injection molding have prevented them from continuing to research and develop technology using microcellular foams.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel pharmaceutical dosage forms and method for producing same
  • Novel pharmaceutical dosage forms and method for producing same
  • Novel pharmaceutical dosage forms and method for producing same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0128] Xylitol 25%

[0129] Hydroxypropylcellulose, grade EF 74%

[0130] Glyceryl Monostearate 1%

[0131] Result: extrusion failed

Embodiment 2

[0133] Xylitol 25%

[0134] Hydroxypropylcellulose, grade EF 69%

[0135] Croscarmellose Sodium 5%

[0136] Glyceryl Monostearate 1%

[0137] Result: Extruded successfully, but not instant

Embodiment 3

[0139] Xylitol 74%

[0140] Hydroxypropylcellulose, grade EF 20%

[0141] Croscarmellose Sodium 5%

[0142] Glyceryl Monostearate 1%

[0143] Result: extrusion failed

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
voidageaaaaaaaaaa
Login to View More

Abstract

Pharmaceutical dosage forms are produced by injection molding mixtures of active agent and polymers under pressure in the presence of gases or supercritical fluids. The rapid release of pressure causes the mixture to form a microporous or ultramicroporous solid. Pressure release takes place inside the mold. The method is especially useful for producing long-lasting fast-dissolving and gastric-retentive tablets.

Description

field of invention [0001] The present invention relates generally to pharmaceutical dosage forms and their manufacture, and more particularly to novel dosage forms in which an active agent is combined with a solid excipient having a foam structure. Background of the invention [0002] Pharmaceutical formulations, especially solid formulations for oral administration, are often provided in the form of so-called "fast dissolving" tablets, which dissolve almost instantaneously, ie within seconds, when they come into contact with saliva in the patient's mouth. Fast-dissolving tablets are especially ideal for use as solid pediatric oral formulations and for dosing adult patients who have difficulty swallowing tablets. [0003] Fast dissolving tablets generally utilize special high solubility formulations and disintegration promoters, and also have a high surface area / volume ratio to facilitate rapid dissolution. In the past, fast-dissolving tablets could not be post-molded due t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/26A61K9/00A61K9/14A61K9/20A61K47/04A61K47/10A61K47/12A61K47/14A61K47/32A61K47/34A61K47/36A61K47/38
CPCA61J3/10A61J2200/20A61K9/0056A61K9/0065A61K9/2095
Inventor 阿伦·J·克拉克
Owner SMITHKLINE BECKMAN CORP